| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |